Search

everythinglearnresearchcommunity

for

Search:↓

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Adalimumab improved folliculitis decalvans in most patients.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

A new cosmetic cream reduced facial redness and skin temperature after 4 weeks of use.

A patient got a skin reaction on their hands and feet after using secukinumab for psoriasis.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

Two women experienced temporary hair loss and other side effects from imiquimod treatment for cervical issues, which stopped after ending the treatment.

Rosacea is a common skin condition mainly causing facial redness.

A woman with dermatomyositis improved after treatment for neck panniculitis, suggesting similar treatment for related conditions.

A man developed severe skin reactions after using a treatment for hair loss.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Red dots on the upper chest may be an early sign of certain types of hair loss.

Red, swollen skin patches are a common allergic reaction to heparin injections, and testing with different heparin types can help find a suitable treatment.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Secukinumab treatment may cause HBV reactivation and hair discoloration.